trending Market Intelligence /marketintelligence/en/news-insights/trending/sjqoyducjaqo1f6wekqlwg2 content esgSubNav
In This List

Acasti Pharma raises further C$1.5M via offering of units

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Acasti Pharma raises further C$1.5M via offering of units

Canada's Acasti Pharma Inc. agreed to issue about C$1.5 million of units to the underwriter of its recently closed securities offering, which helped raise C$10 million.

The underwriter, Mackie Research Capital Corp., exercised its overallotment option to buy an additional 1,429,500 units at C$1.05 each from the company.

Acasti Pharma will use the net proceeds from the offering and overallotment to advance its drug pipeline.